» Articles » PMID: 16293754

Structure of the Quaternary Complex of Interleukin-2 with Its Alpha, Beta, and Gammac Receptors

Overview
Journal Science
Specialty Science
Date 2005 Nov 19
PMID 16293754
Citations 217
Authors
Affiliations
Soon will be listed here.
Abstract

Interleukin-2 (IL-2) is an immunoregulatory cytokine that acts through a quaternary receptor signaling complex containing alpha (IL-2Ralpha), beta (IL-2Rbeta), and common gamma chain (gc) receptors. In the structure of the quaternary ectodomain complex as visualized at a resolution of 2.3 angstroms, the binding of IL-2Ralpha to IL-2 stabilizes a secondary binding site for presentation to IL-2Rbeta. gammac is then recruited to the composite surface formed by the IL-2/IL-2Rbeta complex. Consistent with its role as a shared receptor for IL-4, IL-7, IL-9, IL-15, and IL-21, gammac forms degenerate contacts with IL-2. The structure of gammac provides a rationale for loss-of-function mutations found in patients with X-linked severe combined immunodeficiency diseases (X-SCID). This complex structure provides a framework for other gammac-dependent cytokine-receptor interactions and for the engineering of improved IL-2 therapeutics.

Citing Articles

SHR-1916: A Novel PEGylated Interleukin-2 Analogue with Altered Cellular Selectivity and Improved Pharmacokinetic Profiles for Cancer Immunotherapy.

Kong X, Lin Y, Ouyang C, Chen H, Gao X Drug Des Devel Ther. 2025; 19:1251-1270.

PMID: 40026336 PMC: 11869757. DOI: 10.2147/DDDT.S493011.


A CD25-CCR7 complex initiates non-canonical IL-2 signaling.

Kim S, Lee H, Gingras A, Ley K, Spangler J, Ginsberg M bioRxiv. 2025; .

PMID: 39975281 PMC: 11838579. DOI: 10.1101/2025.02.03.636356.


The IL-2 SYNTHORIN molecule promotes functionally adapted Tregs in a preclinical model of type 1 diabetes.

Alvarez F, Acuff N, La Muraglia 2nd G, Sabri N, Milla M, Mooney J JCI Insight. 2024; 9(24).

PMID: 39704171 PMC: 11665582. DOI: 10.1172/jci.insight.182064.


Harnessing the biology of regulatory T cells to treat disease.

Wardell C, Boardman D, Levings M Nat Rev Drug Discov. 2024; 24(2):93-111.

PMID: 39681737 DOI: 10.1038/s41573-024-01089-x.


A novel vesicular stomatitis virus armed with IL-2 mimic for oncolytic therapy.

Wu M, Wang Y, Wu C, Huang H, Zhou X, Wang J Virol Sin. 2024; 39(5):821-832.

PMID: 39299564 PMC: 11738782. DOI: 10.1016/j.virs.2024.09.007.